New Vernon Capital Holdings II’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Hold
11,704
0.16% 34
2026
Q1
$250K Hold
11,704
0.18% 32
2025
Q4
$250K Hold
11,704
0.12% 44
2025
Q3
$196K Buy
+11,704
New +$175K 0.09% 55
2024
Q1
Sell
-30,029
Closed -$279K 88
2023
Q4
$279K Buy
+30,029
New +$311K 0.15% 60
2023
Q3
Sell
-12,969
Closed -$184K 70
2023
Q2
$184K Buy
+12,969
New +$182K 0.12% 63

Other funds holding MD

New Vernon Capital Holdings II's MD Position: Q2 2026 in Review

New Vernon Capital Holdings II held its Pediatrix Medical (MD) position steady in Q2 2026 at 11,704 shares worth $296K. The position accounts for 0.16% of the portfolio, ranked #34.

New Vernon Capital Holdings II first reported a position in MD in Q2 2023 and has held it in 6 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • New Vernon Capital Holdings II held 11,704 shares of Pediatrix Medical worth $296K as of Q2 2026.
  • New Vernon Capital Holdings II left its Pediatrix Medical share count unchanged in Q2 2026.
  • Pediatrix Medical made up 0.16% of New Vernon Capital Holdings II's portfolio in Q2 2026, its #34 holding.
  • New Vernon Capital Holdings II first reported a position in Pediatrix Medical in Q2 2023 and has held it in 6 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on New Vernon Capital Holdings II's 13F filing for Q2 2026, filed 14 Aug 2026.